Modeling-Based Response-Guided Glecaprevir-Pibrentasvir Therapy for Chronic Hepatitis C to Identify Patients for Ultrashort Treatment Duration. [electronic resource]
Producer: 20210304Description: 1165-1169 p. digitalISSN:- 1537-6613
- Aged
- Aged, 80 and over
- Amides -- administration & dosage
- Antiviral Agents -- administration & dosage
- Benzimidazoles -- administration & dosage
- Carbamates -- administration & dosage
- Cyclopropanes -- administration & dosage
- Drug Administration Schedule
- Drug Combinations
- Drug Therapy, Combination
- Duration of Therapy
- Female
- Fluorenes -- administration & dosage
- Hepatitis C, Chronic -- drug therapy
- Humans
- Kinetics
- Male
- Middle Aged
- Models, Theoretical
- Pyrrolidines -- administration & dosage
- Quinoxalines -- administration & dosage
- RNA, Viral -- blood
- Retrospective Studies
- Sofosbuvir -- administration & dosage
- Sulfonamides -- administration & dosage
- Sustained Virologic Response
- Time Factors
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.